Results 181 to 190 of about 797,541 (308)

Extravascular implantable cardioverter-defibrillator therapy in patients with genetic heart disease: An early single-center experience

open access: yesHeart Rhythm O2
Roxanne Coderre, MD   +10 more
doaj   +1 more source

Machine learning to predict long-term cardiovascular death following myocardial infarction: incremental value of echocardiographic data. [PDF]

open access: yesEur Heart J Digit Health
Scanlon L   +7 more
europepmc   +1 more source

Inside‐Outside ROS Therapeutic Strategy Based on Piezoelectric Nano‐Urchin for Drug‐Resistant Bacteria Biofilm Infections

open access: yesAdvanced Science, EarlyView.
The contribution of this study lies not only in enabling effective treatment of drug‐resistant biofilm infections, but also in establishing a transferable therapeutic paradigm: Ultrasound‐triggered mechanical forces synergistically enhance piezoelectric polarization and nanozyme activity, driving functional ROS generation inside and outside biofilms ...
Xinjian Guo   +5 more
wiley   +1 more source

Photothermal Amplification via Nanorobotic Swarming Dynamics

open access: yesAdvanced Science, EarlyView.
This study explores a novel approach to enhance photothermal therapy using magnetically regulated microswarms. It details the development of magnetic nanoparticles organized into dynamic structures that improve heat retention and conversion efficiency.
Qinglong Wang   +8 more
wiley   +1 more source

Prognostic Impact of Cardiac Diastolic Function and Coronary Microvascular Function on Cardiovascular Death. [PDF]

open access: yesJ Am Heart Assoc, 2023
Hong D   +13 more
europepmc   +1 more source

Prevention of premature cardiovascular death worldwide

open access: yesThe Lancet, 2020
Read, Stephanie H   +1 more
openaire   +3 more sources

RNA‐Binding Protein RBM25 Targets the mRNA Stability of GTPase Rab22a to Restrict Viral Entry and Infection

open access: yesAdvanced Science, EarlyView.
This study identifies RNA‐binding protein RBM25 as a broad‐spectrum antiviral factor acting independently of type I interferon. It blocks viral entry by suppressing GTPase Rab22a via the RC3H1‐mediated destabilization of Rab22a mRNA. Viral downregulation of RBM25 enhances GTPase Rab22a expression and viral entry, revealing an unreported post ...
Yingying Ding   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy